GSK and RB desert Pfizer
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
GlaxoSmithKline (GSK) and Reckitt Benckiser (RB) have pulled out of the race to acquire Pfizer Consumer Healthcare, with both firms separately confirming that they had ended talks with the US pharmaceuticals giant.